Comparing the current results to its competitors, Nautilus Biotechnology Inc reported Revenue decrease in the 1 quarter 2026 year on year by 0 %, despite the revenue increase by the most of its competitors of 5.09 %, recorded in the same quarter.
Nautilus Biotechnology Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 11.03 %
Nautilus Biotechnology Inc 's Comment on Competition and Industry Peers
Nautilus operates in the life sciences market specializing in multiplexed and high-throughput proteomic analysis. Its primary competitors include Thermo Fisher Scientific (including Olink), Bruker Corporation, Agilent Technologies, Danaher (SCIEX), Becton, Dickinson and Company, Quanterix, and Illumina, Inc., which acquired the former Somalogic business from Standard Biotools, Inc. The company also faces competition from emerging firms developing proteomic products and solutions, some of which have advanced commercialization and marketing efforts. Nautilus utilizes proprietary technologies and detailed protein modification mapping capabilities within its high-throughput, massively parallel proteomic platform.
Publicly Traded Peers of Nautilus Biotechnology Inc
Agilent Technologies inc Share Performance
-2.91%
Over The Past 5 Days
Agilent Technologies inc
Profile
Agilent Technologies Inc. operates a business model centered on delivering innovative measurement solutions across industries like life sciences, diagnostics, and chemical analysis. Their revenue primarily comes from sales of instruments, software, and consumables, supplemented by support services. The company emphasizes strong partnerships and collaborations to enhance their market presence and influence.
Standard Biotools Inc operates as a biotechnology company that specializes in the development and distribution of standard laboratory tools and reagents. They offer a diverse range of high-quality products including lab equipment, molecular diagnostics, and research reagents to meet the needs of scientists and researchers in the life sciences industry. With a customer-centric approach, Standard Biotools aims to provide reliable and affordable solutions to support advancements in scientific research and discovery.
Mettler toledo International Inc Share Performance
+11.55%
This Quarter
Mettler toledo International Inc
Profile
Mettler Toledo International Inc. operates on a business model that focuses on providing high-quality precision instruments and solutions tailored for various industries, including pharmaceuticals, food production, and laboratory research. The company emphasizes innovation and customer-centric service, delivering advanced technology and software alongside its instruments to enhance operational efficiency and accuracy. Additionally, Mettler Toledo generates recurring revenue through maintenance services, calibration, and consumables associated with its products, fostering long-term relationships with its clients.
Pacific Biosciences Of California Inc Share Performance
-30.43%
This Year
Pacific Biosciences Of California Inc
Profile
Pacific Biosciences of California Inc's business model revolves around the development and commercialization of innovative sequencing systems that enable scientists and researchers to study the complexity of biology. They provide high-resolution genetic analysis solutions, offering a comprehensive platform that includes consumables, systems, and data analysis software to support genomic analysis.
Sources:
Nautilus Biotechnology Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Nautilus Biotechnology Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
